Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Safety and efficacy of rosiglitazone in the elderly diabetic patient.

Viljoen A, Sinclair A.

Vasc Health Risk Manag. 2009;5(1):389-95. Review.

PMID:
19475776
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Thiazolidinediones in type 2 diabetes: a cardiology perspective.

Khanderia U, Pop-Busui R, Eagle KA.

Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2. Review.

PMID:
18698014
[PubMed - indexed for MEDLINE]
3.

The safety of rosiglitazone in the treatment of type 2 diabetes.

Singh S, Loke YK.

Expert Opin Drug Saf. 2008 Sep;7(5):579-85. doi: 10.1517/14740338.7.5.579 . Review.

PMID:
18759710
[PubMed - indexed for MEDLINE]
4.

Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.

Starner CI, Schafer JA, Heaton AH, Gleason PP.

J Manag Care Pharm. 2008 Jul-Aug;14(6):523-31.

PMID:
18693776
[PubMed - indexed for MEDLINE]
Free Article
5.

A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14,237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone.

Cobitz A, Zambanini A, Sowell M, Heise M, Louridas B, McMorn S, Semigran M, Koch G.

Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):769-81. doi: 10.1002/pds.1615.

PMID:
18613278
[PubMed - indexed for MEDLINE]
6.

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.

PMID:
17551159
[PubMed - indexed for MEDLINE]
Free Article
7.

Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents.

Derosa G.

Drugs. 2010 Oct 22;70(15):1945-61. doi: 10.2165/11538100-000000000-00000. Review.

PMID:
20883052
[PubMed - indexed for MEDLINE]
8.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
[PubMed - indexed for MEDLINE]
9.

Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.

Lu CJ, Sun Y, Muo CH, Chen RC, Chen PC, Hsu CY.

Cerebrovasc Dis. 2013;36(2):145-51. doi: 10.1159/000353679. Epub 2013 Sep 11.

PMID:
24029780
[PubMed - indexed for MEDLINE]
10.

Type 2 diabetes, thiazolidinediones, and cardiovascular risk.

Taylor C, Hobbs FD.

Br J Gen Pract. 2009 Jul;59(564):520-4. doi: 10.3399/bjgp09X453440.

PMID:
19567003
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.

Lebovitz HE, Kreider M, Freed MI.

Diabetes Care. 2002 May;25(5):815-21.

PMID:
11978674
[PubMed - indexed for MEDLINE]
12.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
13.

[Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].

De Flines J, Scheen AJ.

Rev Med Suisse. 2007 Aug 29;3(122):1876, 1878-83. Review. French.

PMID:
17896661
[PubMed - indexed for MEDLINE]
14.

Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.

Hsiao FY, Huang WF, Wen YW, Chen PF, Kuo KN, Tsai YW.

Drug Saf. 2009;32(8):675-90. doi: 10.2165/00002018-200932080-00006.

PMID:
19591532
[PubMed - indexed for MEDLINE]
15.

Effects of the thiazolidinedione medications on micro- and macrovascular complications in patients with diabetes--update 2008.

Rohatgi A, McGuire DK.

Cardiovasc Drugs Ther. 2008 Jun;22(3):233-40. doi: 10.1007/s10557-008-6093-z. Epub 2008 Mar 29. Review.

PMID:
18373186
[PubMed - indexed for MEDLINE]
16.

Review article: Thiazolidinediones and heart failure.

Chaggar PS, Shaw SM, Williams SG.

Diab Vasc Dis Res. 2009 Jul;6(3):146-52. doi: 10.1177/1479164109338772. Review.

PMID:
20368206
[PubMed - indexed for MEDLINE]
Free Article
17.

The "glitazones": rosiglitazone and pioglitazone.

Papoushek C.

J Obstet Gynaecol Can. 2003 Oct;25(10):853-7. Review. Erratum in: J Obstet Gynaecol Can. 2003 Nov;25(11):907.

PMID:
14532954
[PubMed - indexed for MEDLINE]
18.

Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.

Irons BK, Greene RS, Mazzolini TA, Edwards KL, Sleeper RB.

Pharmacotherapy. 2006 Feb;26(2):168-81. Review.

PMID:
16466323
[PubMed - indexed for MEDLINE]
19.

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

Tzoulaki I, Molokhia M, Curcin V, Little MP, Millett CJ, Ng A, Hughes RI, Khunti K, Wilkins MR, Majeed A, Elliott P.

BMJ. 2009 Dec 3;339:b4731. doi: 10.1136/bmj.b4731.

PMID:
19959591
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

Singh S, Loke YK, Furberg CD.

JAMA. 2007 Sep 12;298(10):1189-95.

PMID:
17848653
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk